Log In
Print
BCIQ
Print
Print this Print this
 

DepoVax, DPX-Anthrax

  Manage Alerts
Collapse Summary General Information
Company Immunovaccine Inc.
DescriptionRecombinant protective antigen (rPA) vaccine formulated with ImmunoVaccine's DepoVax vaccine delivery system which uses liposomes to encapsulate a target antigen and adjuvant into an oil depot
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAnthrax
Indication DetailsVaccinate against anthrax
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today